Skip to main content
C

Công ty Cổ phần Y Dược phẩm Vimedimex — Investor Relations & Filings

Ticker · VMD ISIN · VN000000VMD9 HSX Manufacturing
Filings indexed 333 across all filing types
Latest filing 2022-09-07 Board/Management Inform…
Country VN Viet Nam
Listing HSX VMD

About Công ty Cổ phần Y Dược phẩm Vimedimex

www.vietpharm.com.vn/www.vimedimex2-hcm…

Vimedimex Medi-Pharma Joint Stock Company, established in 1984, is a pharmaceutical enterprise. Initially a state-owned entity, it was privatized in 2006. The company's core activities encompass the import, export, and manufacturing of medical and pharmaceutical products. It contributes to the domestic healthcare sector by supplying medicines and medical equipment, aligning with efforts to promote local production over imported alternatives.

Recent filings

Filing Released Lang Actions
VMD: Quyết định của HĐQT về việc bổ nhiệm Phó TGĐ
Board/Management Information Classification · 95% confidence The document is a formal corporate notice from Vimedimex announcing board-level personnel changes (appointment of a Deputy General Director) and includes the Board’s resolution. This matches the description for 'Board/Management Information' (MANG).
2022-09-07 Vietnamese
VMD: Giải trình biến động 5% KQKD HN và riêng soát xét bán niên năm 2022 so với cùng kỳ năm trước
Regulatory Filings Classification · 90% confidence The document is a written explanation letter from Vimedimex to the State Securities Commission and Ho Chi Minh City Stock Exchange detailing why there was more than a 5% variance in profit figures between its reviewed and unreviewed six‐month financial statements. It does not itself contain the financial statements nor is it announcing publication of a report, but rather is a regulatory disclosure explaining variances. This fits the “General regulatory announcements, compliance documents” category (Regulatory Filings).
2022-08-29 Vietnamese
VMD: Giải trình biến động 10% KQKD HN và riêng soát xét bán niên năm 2022 so với cùng kỳ năm trước
Management Reports Classification · 85% confidence The document is a formal letter from Vimedimex to the State Securities Commission and Stock Exchange explaining why the reviewed 6-month consolidated financial results for 2022 have changed by more than 10% compared to the prior year. It provides management’s detailed explanation of revenues, costs, and profit variances rather than the full interim financial statements themselves. This aligns with our definition of a Management Report (MDA), which covers management’s explanation of financial results and business trends.
2022-08-29 Vietnamese
VMD: Giải trình biến động KQKD quý 2/2022 so với cùng kỳ năm trước
Management Reports Classification · 75% confidence The document is a required regulatory letter to the stock exchange and securities commission explaining more than 10% variances in the company’s Q2 2022 operating results versus Q2 2021. It contains management’s narrative analysis of financial performance (revenues, gross profit, expenses, pre‐tax profit, etc.) but does not include the full financial statements. This matches a standalone Management Discussion & Analysis (MDA) disclosure rather than a full interim report or just an earnings highlight. Therefore, it should be classified as MDA.
2022-07-29 Vietnamese
VMD: Báo cáo tình hình quản trị công ty 6 tháng đầu năm 2022
Governance Information Classification · 90% confidence The document is a detailed 6-month corporate governance report (“Báo cáo tình hình quản trị công ty”) covering board activities, supervisory board, resolutions, internal control, and insider transactions. It does not present financial statements or earnings metrics, nor is it merely an announcement of a report. This aligns with the “Governance Information (CGR)” category.
2022-07-28 Vietnamese
VMD: Giấy ủy quyền thực hiện công bố thông tin
Regulatory Filings Classification · 92% confidence The document is a corporate regulatory announcement (“Công bố thông tin bất thường”) disclosing an authorization letter for a company officer to perform information disclosure. It is not a financial report, earnings release, management change notice, or dividend/share event. It is a general compliance/regulatory filing under Vietnamese securities rules. Therefore it falls into the “Regulatory Filings” (RNS) category.
2022-07-04 Vietnamese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.